Viral Hemorrhagic Fevers Other than Ebola and Lassa.

[1]  T. Monath,et al.  Yellow fever. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[2]  G. Ippolito,et al.  Laboratory management of Crimean-Congo haemorrhagic fever virus infections: perspectives from two European networks , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  H. Feldmann,et al.  Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation , 2019, Front. Immunol..

[4]  S. Hallam,et al.  Review of Mammarenavirus Biology and Replication , 2018, Front. Microbiol..

[5]  A. Hartman,et al.  Rift Valley fever in animals and humans: Current perspectives. , 2018, Antiviral research.

[6]  R. Charrel,et al.  Yellow fever in the diagnostics laboratory , 2018, Emerging Microbes & Infections.

[7]  Nguyen Tien Huy,et al.  Definitions for warning signs and signs of severe dengue according to the WHO 2009 classification: Systematic review of literature , 2018, Reviews in medical virology.

[8]  A. Ploss,et al.  Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe. , 2018, Trends in microbiology.

[9]  T. Westling,et al.  Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy , 2018, The New England journal of medicine.

[10]  G. Ippolito,et al.  Prolonged detection of dengue virus RNA in the semen of a man returning from Thailand to Italy, January 2018 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  Å. Lundkvist,et al.  Alkhurma Hemorrhagic Fever Virus RNA in Hyalomma rufipes Ticks Infesting Migratory Birds, Europe and Asia Minor , 2018, Emerging infectious diseases.

[12]  E. Koonin,et al.  Taxonomy of the family Arenaviridae and the order Bunyavirales: update 2018 , 2018, Archives of Virology.

[13]  P. Yadav,et al.  Clinical & epidemiological significance of Kyasanur forest disease , 2018, The Indian journal of medical research.

[14]  T. N. Lima-Camara,et al.  Natural vertical transmission of dengue virus in Aedes aegypti and Aedes albopictus: a systematic review , 2018, Parasites & Vectors.

[15]  M. Halloran,et al.  Antibody-dependent enhancement of severe dengue disease in humans , 2017, Science.

[16]  S. Ross,et al.  New World Arenavirus Biology. , 2017, Annual review of virology.

[17]  G. Coelho,et al.  Symptomatic dengue infection during pregnancy and livebirth outcomes in Brazil, 2007-13: a retrospective observational cohort study. , 2017, The Lancet. Infectious diseases.

[18]  W. Bierman,et al.  Urine as Sample Type for Molecular Diagnosis of Natural Yellow Fever Virus Infections , 2017, Journal of Clinical Microbiology.

[19]  P. Kittayapong,et al.  First evidence of dengue infection in domestic dogs living in different ecological settings in Thailand , 2017, PloS one.

[20]  G. Ippolito,et al.  Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  J. Menárguez,et al.  Autochthonous Crimean-Congo Hemorrhagic Fever in Spain. , 2017, The New England journal of medicine.

[22]  A. Hartman.  Rift Valley Fever. , 2017, Clinics in laboratory medicine.

[23]  A. Marzi,et al.  Ebola and Marburg virus vaccines , 2017, Virus Genes.

[24]  Z. Tong,et al.  Seroprevalence of severe fever with thrombocytopenia syndrome virus in China: A systematic review and meta-analysis , 2017, PloS one.

[25]  B. Gowen,et al.  Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies , 2017, Journal of Microbiology.

[26]  Hong Jiang,et al.  Hantavirus infection: a global zoonotic challenge , 2017, Virologica Sinica.

[27]  J. Farrar,et al.  Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine. , 2016, The Journal of infectious diseases.

[28]  O. O'Connor,et al.  Vertical Transmission of Dengue Virus in the Peripartum Period and Viral Kinetics in Newborns and Breast Milk: New Data , 2016, Journal of the Pediatric Infectious Diseases Society.

[29]  Mary E. Wilson,et al.  Update on non-vector transmission of dengue: relevant studies with Zika and other flaviviruses , 2016, Tropical Diseases, Travel Medicine and Vaccines.

[30]  P. V. van Genderen,et al.  17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients. , 2016, The Journal of infection.

[31]  E. Kroon,et al.  Spatial-Temporal Co-Circulation of Dengue Virus 1, 2, 3, and 4 Associated with Coinfection Cases in a Hyperendemic Area of Brazil: A 4-Week Survey. , 2016, The American journal of tropical medicine and hygiene.

[32]  N. Beeching,et al.  Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002–2014: a multicentre retrospective cross-sectional study , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[33]  A. Anyamba,et al.  Rift Valley Fever: An Emerging Mosquito-Borne Disease. , 2016, Annual review of entomology.

[34]  Hong Jiang,et al.  Hemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical Picture , 2016, Front. Cell. Infect. Microbiol..

[35]  D. Smee,et al.  Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses. , 2016, Antiviral research.

[36]  Jianguo Xu,et al.  The emergence and cross species transmission of newly discovered tick-borne Bunyavirus in China. , 2016, Current opinion in virology.

[37]  G. Olinger,et al.  Viral Hemorrhagic Fever Diagnostics. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  Ali S Khan,et al.  The Risk of Nosocomial Transmission of Rift Valley Fever , 2015, PLoS neglected tropical diseases.

[39]  O. Horstick,et al.  Dengue , 2015, The Lancet.

[40]  N. Johnson,et al.  Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe. , 2015, Vaccine.

[41]  Juno Thomas,et al.  Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease , 2015, Virology Journal.

[42]  S. Mattar,et al.  Diagnosis of hantavirus infection in humans , 2015, Expert review of anti-infective therapy.

[43]  L. Figueiredo,et al.  Hantaviruses--globally emerging pathogens. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[44]  F. Saggioro,et al.  Polymorphisms in human leukocyte antigens, human platelet antigens, and cytokine genes in hantavirus cardiopulmonary syndrome patients from Ribeirão Preto, Brazil , 2014, Journal of medical virology.

[45]  K. Zandi,et al.  Tick-borne viruses: a review from the perspective of therapeutic approaches. , 2014, Ticks and tick-borne diseases.

[46]  Y. Leo,et al.  Challenges in Dengue Fever in the Elderly: Atypical Presentation and Risk of Severe Dengue and Hospita-Acquired Infection , 2014, PLoS neglected tropical diseases.

[47]  P. Vial,et al.  Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology. , 2014, Swiss medical weekly.

[48]  H. Feldmann,et al.  The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster , 2013, Immunology.

[49]  J. Quaresma,et al.  Immunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow fever , 2013, Reviews in medical virology.

[50]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[51]  S. Paessler,et al.  Pathogenesis of the viral hemorrhagic fevers. , 2013, Annual review of pathology.

[52]  K. Stiasny,et al.  Flaviviruses and their antigenic structure. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[53]  Adam J. Hume,et al.  Forty-Five Years of Marburg Virus Research , 2012, Viruses.

[54]  S. Nichol,et al.  Detection, Isolation and Confirmation of Crimean-Congo Hemorrhagic Fever Virus in Human, Ticks and Animals in Ahmadabad, India, 2010–2011 , 2012, PLoS neglected tropical diseases.

[55]  A. MacNeil,et al.  Hantavirus pulmonary syndrome. , 2011, Virus research.

[56]  A. Rothman.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms , 2011, Nature Reviews Immunology.

[57]  Thomas Walz,et al.  The Hexamer Structure of the Rift Valley Fever Virus Nucleoprotein Suggests a Mechanism for its Assembly into Ribonucleoprotein Complexes , 2011, PLoS pathogens.

[58]  Steven B. Bradfute,et al.  Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. , 2011, Antiviral research.

[59]  R. Charrel,et al.  Arenaviruses and hantaviruses: from epidemiology and genomics to antivirals. , 2011, Antiviral research.

[60]  S. Kunz,et al.  Pathogenesis of arenavirus hemorrhagic fevers , 2011, Expert review of anti-infective therapy.

[61]  D. Růžek,et al.  Omsk haemorrhagic fever , 2010, The Lancet.

[62]  E. Gould,et al.  Alkhurma Hemorrhagic Fever in Travelers Returning from Egypt, 2010 , 2010, Emerging infectious diseases.

[63]  G. Ippolito,et al.  Alkhurma Hemorrhagic Fever in Travelers Returning from Egypt, 2010 , 2010, Emerging infectious diseases.

[64]  H. Leblebicioglu.  Crimean-Congo haemorrhagic fever in Eurasia. , 2010, International journal of antimicrobial agents.

[65]  R. Charrel,et al.  The N-Terminal Domain of the Arenavirus L Protein Is an RNA Endonuclease Essential in mRNA Transcription , 2010, PLoS pathogens.

[66]  S. Nichol,et al.  Ebola and marburg hemorrhagic fever. , 2010, Clinics in laboratory medicine.

[67]  G. Dobler.  Zoonotic tick-borne flaviviruses. , 2010, Veterinary microbiology.

[68]  T. Briese,et al.  Z Proteins of New World Arenaviruses Bind RIG-I and Interfere with Type I Interferon Induction , 2009, Journal of Virology.

[69]  Christina L Gardner,et al.  A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection , 2009, PLoS pathogens.

[70]  G. Yılmaz,et al.  The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[71]  C. Herzog,et al.  Evaluation of an Indirect Immunofluorescence Assay for Detection of Immunoglobulin M (IgM) and IgG Antibodies against Yellow Fever Virus , 2007, Clinical and Vaccine Immunology.

[72]  P. Cannon,et al.  New World Clade B Arenaviruses Can Use Transferrin Receptor 1 (TfR1)-Dependent and -Independent Entry Pathways, and Glycoproteins from Human Pathogenic Strains Are Associated with the Use of TfR1 , 2007, Journal of Virology.

[73]  E. Holmes,et al.  Out of Africa: A Molecular Perspective on the Introduction of Yellow Fever Virus into the Americas , 2007, PLoS pathogens.

[74]  K. Hedlund,et al.  Ex Vivo Stability of the Rodent-Borne Hantaan Virus in Comparison to That of Arthropod-Borne Members of the Bunyaviridae Family , 2007, Applied and Environmental Microbiology.

[75]  G. Mertz,et al.  Incubation Period of Hantavirus Cardiopulmonary Syndrome , 2006, Emerging infectious diseases.

[76]  O. Ergonul,et al.  Crimean-Congo haemorrhagic fever , 2006 .

[77]  J. Quaresma,et al.  Revisiting the liver in human yellow fever : Virus-induced apoptosis in hepatocytes associated with TGF-β, TNF-α and NK cells activity , 2006 .

[78]  C. Whitehouse,et al.  Crimean-Congo hemorrhagic fever virus. , 2005, Current molecular medicine.

[79]  T. Madani.  Alkhumra virus infection, a new viral hemorrhagic fever in Saudi Arabia. , 2005, The Journal of infection.

[80]  E. Abboud,et al.  Ocular complications of Rift Valley fever outbreak in Saudi Arabia. , 2005, Ophthalmology.

[81]  T. V. Frolova,et al.  Tick-borne virus diseases of human interest in Europe. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[82]  B. Hjelle,et al.  Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[83]  Ali S Khan,et al.  Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[84]  H. Feldmann,et al.  Viral hemorrhagic fever – a vascular disease? , 2003, Thrombosis and Haemostasis.

[85]  S. Halstead,et al.  Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored , 2002, Emerging infectious diseases.

[86]  B. Hjelle.  Vaccines against hantaviruses , 2002, Expert review of vaccines.

[87]  Philip K. Russell,et al.  Hemorrhagic fever viruses as biological weapons: medical and public health management. , 2002, JAMA.

[88]  A. Rothman,et al.  High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. , 1999, The Journal of infectious diseases.

[89]  A. Zaki.  Isolation of a flavivirus related to the tick-borne encephalitis complex from human cases in Saudi Arabia. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[90]  T. Ksiazek,et al.  Prospects for the control of Bolivian hemorrhagic fever. , 1995, Emerging infectious diseases.

[91]  G. H. Tignor,et al.  Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection , 1993, Antiviral Research.

[92]  J. Leduc,et al.  Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. , 1991, The Journal of infectious diseases.

[93]  D. Nash,et al.  Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. , 1989, The American journal of tropical medicine and hygiene.

[94]  C. L. Bailey,et al.  Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya , 1985, Journal of Hygiene.

[95]  J. Maiztegui,et al.  EFFICACY OF IMMUNE PLASMA IN TREATMENT OF ARGENTINE HÆMORRHAGIC FEVER AND ASSOCIATION BETWEEN TREATMENT AND A LATE NEUROLOGICAL SYNDROME , 1979, The Lancet.

[96]  T. Bothwell,et al.  Outbreake of Marburg virus disease in Johannesburg. , 1975, British medical journal.

[97]  H. Feldmann,et al.  Filoviruses: Ecology, Molecular Biology, and Evolution. , 2018, Advances in virus research.

[98]  Dengue vaccine: WHO position paper, September 2018 - Recommendations. , 2018, Vaccine.

[99]  H. Ly,et al.  Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. , 2014, The Journal of general virology.

[100]  T. Ksiazek,et al.  Alkhumra (Alkhurma) virus outbreak in Najran, Saudi Arabia: epidemiological, clinical, and laboratory characteristics. , 2011, The Journal of infection.

[101]  R. Charrel,et al.  Arenaviruses other than Lassa virus. , 2003, Antiviral research.

[102]  S. Günther,et al.  Molecular diagnostics of viral hemorrhagic fevers. , 2003, Antiviral research.

[103]  A. Barrett,et al.  Epidemiology and ecology of yellow fever virus. , 2003, Advances in virus research.

[104]  V. Alves,et al.  Human fatal yellow fever. Immunohistochemical detection of viral antigens in the liver, kidney and heart. , 1992, Pathology, research and practice.